Date published: 2026-4-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

mGLuR-8 Inhibitors

mGluR-8 inhibitors belong to a distinctive class of chemical compounds designed to modulate the metabotropic glutamate receptor subtype 8 (mGluR-8). These receptors are part of the G protein-coupled receptor family and play a crucial role in the central nervous system, particularly in regulating neurotransmitter activity. mGluR-8, one of the eight known subtypes of metabotropic glutamate receptors, is primarily expressed in regions of the brain such as the cerebellum, where it contributes to the modulation of synaptic transmission. The chemical entities classified as mGluR-8 inhibitors exert their effects by selectively binding to the mGluR-8 receptor, leading to the inhibition of its signaling cascade. mGluR-8 inhibitors often feature distinct chemical scaffolds that enable specific interactions with the receptor's binding site. These compounds typically act as antagonists, blocking the receptor's activation in response to glutamate, the endogenous ligand. By interfering with mGluR-8 signaling, these inhibitors can influence synaptic transmission and neuronal excitability. Understanding the structural and pharmacological properties of mGluR-8 inhibitors is essential for elucidating their mode of action and potential implications in the context of neurological processes. Ongoing research focuses on refining the design of these inhibitors to enhance their selectivity, affinity, and pharmacokinetic properties, paving the way for a deeper understanding of the intricacies of mGluR-8 modulation and its implications in neurobiology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(RS)-CPPG

183364-82-1sc-203448
sc-203448A
5 mg
25 mg
$416.00
$1248.00
1
(0)

(RS)-CPPG is a selective mGluR-8 modulator characterized by its unique chiral configuration, which enhances its affinity for the receptor's binding site. The compound's distinct molecular architecture promotes specific hydrogen bonding and hydrophobic interactions, optimizing receptor engagement. Its dynamic binding kinetics allow for precise modulation of receptor activity, potentially influencing intracellular signaling pathways and neuronal communication. The compound's stereochemistry may also play a role in its interaction with other molecular targets, further diversifying its functional profile.

(RS)-MCPG

146669-29-6sc-202325
5 mg
$137.00
(0)

A competitive antagonist at mGluR-8 and other group II metabotropic glutamate receptors, which may reduce mGluR-8 mediated signaling.

UBP1112

339526-74-8sc-204368
sc-204368A
10 mg
50 mg
$686.00
$1509.00
2
(0)

UBP1112 is a selective modulator of mGluR-8, distinguished by its unique structural features that facilitate specific electrostatic interactions with the receptor. This compound exhibits a remarkable ability to stabilize the receptor in an active conformation, enhancing its signaling efficacy. The intricate balance of hydrophilic and lipophilic regions within UBP1112 contributes to its favorable binding kinetics, allowing for nuanced regulation of downstream signaling cascades. Its conformational flexibility may also enable interactions with various protein partners, broadening its functional implications.

MTPG

169209-66-9sc-204106
sc-204106A
5 mg
50 mg
$119.00
$709.00
(0)

MTPG is a selective mGluR-8 modulator characterized by its unique binding affinity and conformational adaptability. This compound engages in specific hydrogen bonding and hydrophobic interactions with the receptor, promoting a distinct allosteric modulation. MTPG's kinetic profile reveals a rapid association and dissociation rate, allowing for precise temporal control of receptor activity. Its structural diversity enhances the potential for unique interactions with cellular pathways, influencing downstream effects.

(RS)-MSPG

169209-64-7sc-203247
sc-203247A
5 mg
10 mg
$48.00
$201.00
(0)

(RS)-MSPG is a selective modulator of mGluR-8, distinguished by its ability to stabilize receptor conformations through unique electrostatic interactions. This compound exhibits a notable capacity for allosteric enhancement, facilitating nuanced signaling pathways. Its dynamic binding kinetics enable swift receptor activation, while its structural features promote specific interactions with lipid membranes, potentially influencing receptor localization and function within neuronal networks.

L-γ-Carboxyglutamic acid

53861-57-7sc-295277
sc-295277A
10 mg
50 mg
$402.00
$1047.00
(0)

L-γ-Carboxyglutamic acid serves as a selective modulator of mGluR-8, characterized by its ability to engage in specific hydrogen bonding and ionic interactions that influence receptor dynamics. This compound demonstrates a unique capacity for conformational flexibility, allowing it to adapt to various binding sites. Its interactions with surrounding molecular environments can alter receptor affinity and efficacy, potentially impacting downstream signaling cascades in neural pathways.

(S)-MCPG

150145-89-4sc-202329
sc-202329A
5 mg
25 mg
$146.00
$964.00
(0)

An enantiomer of MCPG, which acts as a competitive antagonist of mGluR-8 and can inhibit its signaling.

2-Phenylglycine

2835-06-5sc-238199
100 g
$38.00
(0)

An mGluR antagonist that can interact with mGluR-8 and attenuate its signal transduction.

MPPG

169209-65-8sc-203143
sc-203143A
10 mg
50 mg
$175.00
$739.00
(0)

A selective antagonist for group II metabotropic glutamate receptors that can decrease activity at the mGluR-8 site.

MAP4

157381-42-5sc-202221
5 mg
$40.00
(0)

A negative allosteric modulator of mGluR-8, directly inhibiting its function.